Takaoka H, Miyamura T, Shimada K
SAGE Open Med. 2024; 12:20503121241277498.
PMID: 39315386
PMC: 11418348.
DOI: 10.1177/20503121241277498.
Lend K, Lampa J, Padyukov L, Hetland M, Heiberg M, Nordstrom D
Ann Rheum Dis. 2024; 83(12):1657-1665.
PMID: 39079894
PMC: 11671985.
DOI: 10.1136/ard-2024-226024.
Cha S, Bang S, Joo Y, Cho S, Choi C, Sung Y
Sci Rep. 2024; 14(1):6763.
PMID: 38514707
PMC: 10957942.
DOI: 10.1038/s41598-024-56987-2.
Harrold L, Wittstock K, Kelly S, Han X, Zhuo J, Schrader A
Adv Rheumatol. 2024; 64(1):10.
PMID: 38243281
DOI: 10.1186/s42358-024-00352-4.
Iwasaki T, Watanabe R, Ito H, Fujii T, Ohmura K, Yoshitomi H
Arthritis Res Ther. 2024; 26(1):1.
PMID: 38167328
PMC: 10759752.
DOI: 10.1186/s13075-023-03236-y.
Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis.
Inoue M, Nagafuchi Y, Ota M, Tsuchiya H, Tateishi S, Kanda H
Sci Rep. 2023; 13(1):15250.
PMID: 37709837
PMC: 10502099.
DOI: 10.1038/s41598-023-42324-6.
Clinical Implications of Shared Epitope and Anti-citrullinated Peptide Antibody in Patients With Rheumatoid Arthritis.
Jung S, Park Y, Park K, Kim K
J Rheum Dis. 2023; 29(3):171-180.
PMID: 37475973
PMC: 10324929.
DOI: 10.4078/jrd.2022.29.3.171.
HLA-DRB1 Is Associated with Therapeutic Responsiveness in IgG4-related Disease.
Yamamoto M, Tanaka T, Aochi S, Uehara M
Intern Med. 2023; 63(2):207-211.
PMID: 37225483
PMC: 10864075.
DOI: 10.2169/internalmedicine.1847-23.
The Search for the Pathogenic T Cells in the Joint of Rheumatoid Arthritis: Which T-Cell Subset Drives Autoimmune Inflammation?.
Yamada H
Int J Mol Sci. 2023; 24(8).
PMID: 37108093
PMC: 10138952.
DOI: 10.3390/ijms24086930.
Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis.
Hirose W, Harigai M, Amano K, Hidaka T, Itoh K, Aoki K
Rheumatol Adv Pract. 2022; 6(3):rkac090.
PMID: 36407801
PMC: 9667967.
DOI: 10.1093/rap/rkac090.
Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search.
Roodenrijs N, Welsing P, van Roon J, Schoneveld J, van der Goes M, Nagy G
Rheumatology (Oxford). 2022; 61(9):3552-3566.
PMID: 35238332
PMC: 9434144.
DOI: 10.1093/rheumatology/keac114.
The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity.
Zhuo J, Xia Q, Sharma N, Gao S, Lama S, Cui J
Rheumatol Ther. 2022; 9(2):637-647.
PMID: 35174462
PMC: 8964857.
DOI: 10.1007/s40744-022-00427-y.
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA.
Rigby W, Buckner J, Bridges Jr S, Nys M, Gao S, Polinsky M
Arthritis Res Ther. 2021; 23(1):245.
PMID: 34537057
PMC: 8449494.
DOI: 10.1186/s13075-021-02607-7.
Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis.
Hirose W, Harigai M, Amano K, Hidaka T, Itoh K, Aoki K
Arthritis Res Ther. 2021; 23(1):228.
PMID: 34465391
PMC: 8407060.
DOI: 10.1186/s13075-021-02612-w.
Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA.
Harrold L, Bryson J, Lehman T, Zhuo J, Gao S, Han X
Rheumatol Ther. 2021; 8(2):937-953.
PMID: 34047953
PMC: 8217398.
DOI: 10.1007/s40744-021-00310-2.
High serum IgA and activated Th17 and Treg predict the efficacy of abatacept in patients with early, seropositive rheumatoid arthritis.
Inamo J, Kaneko Y, Kikuchi J, Takeuchi T
Clin Rheumatol. 2021; 40(9):3615-3626.
PMID: 33704594
DOI: 10.1007/s10067-021-05602-0.
A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity.
Park S, Han X, Lobo F, Nanji S, Patel D
Clinicoecon Outcomes Res. 2020; 12:589-594.
PMID: 33116698
PMC: 7571575.
DOI: 10.2147/CEOR.S263903.
Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis-From Research to Clinical Practice.
Wysocki T, Olesinska M, Paradowska-Gorycka A
Cells. 2020; 9(5).
PMID: 32370106
PMC: 7291248.
DOI: 10.3390/cells9051127.
